GB201510764D0 - bis-Pyridazine compounds and their use in treating cancer - Google Patents

bis-Pyridazine compounds and their use in treating cancer

Info

Publication number
GB201510764D0
GB201510764D0 GBGB1510764.2A GB201510764A GB201510764D0 GB 201510764 D0 GB201510764 D0 GB 201510764D0 GB 201510764 A GB201510764 A GB 201510764A GB 201510764 D0 GB201510764 D0 GB 201510764D0
Authority
GB
United Kingdom
Prior art keywords
bis
treating cancer
pyridazine compounds
pyridazine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1510764.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTRAZENECA AND CANCER RES TECHNOLOGY Ltd AB
Original Assignee
ASTRAZENECA AND CANCER RES TECHNOLOGY Ltd AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTRAZENECA AND CANCER RES TECHNOLOGY Ltd AB filed Critical ASTRAZENECA AND CANCER RES TECHNOLOGY Ltd AB
Priority to GBGB1510764.2A priority Critical patent/GB201510764D0/en
Publication of GB201510764D0 publication Critical patent/GB201510764D0/en
Ceased legal-status Critical Current

Links

GBGB1510764.2A 2015-06-18 2015-06-18 bis-Pyridazine compounds and their use in treating cancer Ceased GB201510764D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1510764.2A GB201510764D0 (en) 2015-06-18 2015-06-18 bis-Pyridazine compounds and their use in treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1510764.2A GB201510764D0 (en) 2015-06-18 2015-06-18 bis-Pyridazine compounds and their use in treating cancer

Publications (1)

Publication Number Publication Date
GB201510764D0 true GB201510764D0 (en) 2015-08-05

Family

ID=53784160

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1510764.2A Ceased GB201510764D0 (en) 2015-06-18 2015-06-18 bis-Pyridazine compounds and their use in treating cancer

Country Status (1)

Country Link
GB (1) GB201510764D0 (en)

Similar Documents

Publication Publication Date Title
ZA201904695B (en) Amino-triazolopyridine compounds and their use in treating cancer
HK1243005A1 (en) Anti-lilrb antibodies and their use in detecting and treating cancer
HK1245287A1 (en) IL13RAα2 BINDING AGENTS AND USE THEREOF IN CANCER TREATMENT
HK1256283A1 (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
IL276733A (en) Use of eribulin in the treatment of cancer
HRP20181490T1 (en) 1, 3, 4-thiadiazole compounds and their use in treating cancer
GB201511382D0 (en) Novel compounds and their use in therapy
IL251903B (en) Apilimod for use in the treatment of colorectal cancer
GB201420533D0 (en) Use of Nanomaterials in treating cancer
ZA201804361B (en) 1,3,4-thiadiazole compounds and their use in treating cancer
IL259510A (en) 1,3,4-thiadiazole compounds and their use in treating cancer
IL261648A (en) Cinnolin-4-amine compounds and their use in treating cancer
IL262143A (en) Improvements in cancer treatment
ZA201802618B (en) Anti-cd43 antibody and use thereof for cancer treatment
IL259358A (en) Bis-pyridazine compounds and their use in treating cancer
SG10202001388YA (en) Use of ureidomustine (bo-1055) in cancer treatment
IL258644A (en) 1,3,4-thiadiazole compounds and their use in treating cancer
IL255541A (en) Cabazitaxel and its use for treating cancer
GB2578008B (en) 1-Acetyl-5-Nitro-4-Phenyl-3-Pyrrolin-2-one for use in cancer treatment
GB201510764D0 (en) bis-Pyridazine compounds and their use in treating cancer
GB201411111D0 (en) bis-Pyridazine compounds and their use in treating cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)